Jefferson Torresdale Hospital — Philadelphia, Pennsylvania

Jefferson Torresdale Hospital is a clinical research site located in Philadelphia, Pennsylvania, United States 19114.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Jefferson Torresdale Hospital has participated in 67 clinical trials with 52 currently active.

Therapeutic areas: Covid-19 Vaccine, Vaccine Hesitancy, Metastatic Head and Neck Squamous Cell Carcinoma.

Sponsors: University of California, San Francisco, National Cancer Institute (NCI), NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jefferson Torresdale Hospital?

Jefferson Torresdale Hospital has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jefferson Torresdale Hospital conducted?

Jefferson Torresdale Hospital has 67 clinical trials on record, with 52 currently active. Their work covers Covid-19 Vaccine, Vaccine Hesitancy, Metastatic Head and Neck Squamous Cell Carcinoma.

Is Jefferson Torresdale Hospital accredited by Crixeo Clinical Trials?

Jefferson Torresdale Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jefferson Torresdale Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.